These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3490304)

  • 1. Retinoic acid restores normal growth control to a transformed mouse embryo fibroblast cell line.
    Levine AE; Crandall CA; Brattain D; Chakrabarty S; Brattain MG
    Cancer Lett; 1986 Oct; 33(1):33-43. PubMed ID: 3490304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide.
    Chakrabarty S; McRae LJ; Levine AE; Brattain MG
    Cancer Res; 1984 May; 44(5):2181-5. PubMed ID: 6608991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective phosphorylation of cytosol proteins associated with transformation and restoration of normal phenotype in AKR mouse embryo fibroblasts.
    Chakrabarty S; Jan Y; Son J; Miller CA; Brattain MG
    Cancer Res; 1985 May; 45(5):2170-6. PubMed ID: 3872713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
    Levine AE; McRae LJ; Brattain MG
    Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM; Levine AE; Hinshaw XH
    Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of difluoromethylornithine and dicyclohexylammonium sulfate on the transformed state of AKR-MCA cells.
    Boyd D; Bialoski S; Brattain MG
    Cancer Res; 1987 Aug; 47(15):4099-104. PubMed ID: 3111681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a serum-free culture system comparing growth factor requirements of transformed and untransformed cells.
    Mulder KM; Childress-Fields KE
    Exp Cell Res; 1990 Jun; 188(2):254-61. PubMed ID: 2185944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cellular phosphoprotein profiles in transformation and redifferentiation of murine AKR embryonic fibroblastic cells.
    Chakrabarty S; Brattain MG
    Cancer Lett; 1985 Nov; 29(2):151-5. PubMed ID: 3865700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of transforming growth factor beta, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts.
    Hoosein NM; Brattain DE; McKnight MK; Brattain MG
    Exp Cell Res; 1988 Mar; 175(1):125-35. PubMed ID: 3162213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth inhibitory activity in transformed mouse embryo fibroblasts.
    Levine AE; Crandall CA; Brattain MG
    Exp Cell Res; 1987 Aug; 171(2):357-66. PubMed ID: 2887448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Levine AE; Crandall CA
    Cancer Res; 1987 Aug; 47(16):4278-82. PubMed ID: 3496961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors, growth factor receptors, and cell cycle control mechanisms in chemically transformed cells.
    Moses HL; Robinson RA
    Fed Proc; 1982 Nov; 41(13):3008-11. PubMed ID: 6292004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
    Pietenpol JA; Howe PH; Cunningham MR; Leof EB
    J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of epidermal growth factor receptor induction by retinoic acid in a chemically transformed rat liver cell line.
    Raymond VW; Grisham JW; Earp HS
    Cell Growth Differ; 1990 Sep; 1(9):393-9. PubMed ID: 2288880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the actions and interactions of retinoic acid and epidermal growth factor on transformed urothelial cells in culture: implications for the use of retinoid therapy in the treatment of bladder cancer patients.
    Nutting C; Chowaniec J
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):51-5. PubMed ID: 1310606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.